THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced...
Biotech drugmaker Human Genome Sciences Inc.'s board has adopted a "poison pill"...
Hikma Pharmaceuticals Plc said it expects profitability in its generics business to...
LOS ANGELES--(BUSINESS WIRE)-- KYTHERA Biopharmaceuticals, Inc. (KYTHERA), a clinical-stage biopharmaceutical company focused...
Infants who show developmental delays in head and neck muscle control may...
Three years ago, a former Bristol-Myers Squibb senior vice president named Andrew...
Download the Levin & Company Corporate Brochure here.
